Considerations for the Surgical Management of Thoracic Cancers During the COVID-19 Pandemic: Rational Strategies for Thoracic Surgeons

被引:2
作者
Zhang, Jiahao [1 ]
Han, Yichao [1 ]
Zhang, Yajie [1 ]
Dong, Dong [1 ]
Cao, Yuqin [1 ]
Chen, Xiang [1 ]
Li, Hecheng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Thorac Surg, Sch Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
COVID-19; early-stage lung cancer; esophageal cancer; ground glass opacities; recommendation; prevention of nosocomial transmission in hospitals; thoracic surgeons; surgical treatment; LUNG-CANCER; BASE-LINE; ADENOCARCINOMA; PNEUMONIA; NODULES; LESIONS; WUHAN; TIME;
D O I
10.3389/fsurg.2022.742007
中图分类号
R61 [外科手术学];
学科分类号
摘要
ObjectiveThe novel Coronavirus Disease 2019 (COVID-19) has resulted in a global health crisis since first case was identified in December 2019. As the pandemic continues to strain global public health systems, elective surgeries for thoracic cancer, such as early-stage lung cancer and esophageal cancer (EC), have been postponed due to a shortage of medical resources and the risk of nosocomial transmission. This review is aimed to discuss the influence of COVID-19 on thoracic surgical practice, prevention of nosocomial transmission during the pandemic, and propose modifications to the standard practices in the surgical management of different thoracic cancer. MethodsA literature search of PubMed, Medline, and Google Scholar was performed for articles focusing on COVID-19, early-stage lung cancer, and EC prior to 1 July 2021. The evidence from articles was combined with our data and experience. ResultsWe review the challenges in the management of different thoracic cancer from the perspectives of thoracic surgeons and propose rational strategies for the diagnosis and treatment of early-stage lung cancer and EC during the COVID-19 pandemic. ConclusionsDuring the COVID-19 pandemic, the optimization of hospital systems and medical resources is to fight against COVID-19. Indolent early lung cancers, such as pure ground-glass nodules/opacities (GGOs), can be postponed with a lower risk of progression, while selective surgeries of more biologically aggressive tumors should be prioritized. As for EC, we recommend immediate or prioritized surgeries for patients with stage Ib or more advanced stage and patients after neoadjuvant therapy. Routine COVID-19 screening should be performed preoperatively before thoracic surgeries. Prevention of nosocomial transmission by providing appropriate personal protective equipment (PPE), such as N-95 respirator masks with eye protection to healthcare workers, is necessary.
引用
收藏
页数:7
相关论文
共 41 条
[1]  
[Anonymous], AM COLL SURGEONS ACS
[2]  
Antonoff M, 2020, ANN THORAC SURG, V110, P692, DOI [10.1016/j.athoracsur.2020.03.005, 10.1016/j.jtcvs.2020.03.061]
[3]   Real estimates of mortality following COVID-19 infection [J].
Baud, David ;
Qi, Xiaolong ;
Nielsen-Saines, Karin ;
Musso, Didier ;
Pomar, Leo ;
Favre, Guillaume .
LANCET INFECTIOUS DISEASES, 2020, 20 (07) :773-773
[4]   Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China [J].
Cheng, Zenghui ;
Lu, Yong ;
Cao, Qiqi ;
Qin, Le ;
Pan, Zilai ;
Yan, Fuhua ;
Yang, Wenjie .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (01) :121-126
[5]   CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) [J].
Chung, Michael ;
Bernheim, Adam ;
Mei, Xueyan ;
Zhang, Ning ;
Huang, Mingqian ;
Zeng, Xianjun ;
Cui, Jiufa ;
Xu, Wenjian ;
Yang, Yang ;
Fayad, Zahi A. ;
Jacobi, Adam ;
Li, Kunwei ;
Li, Shaolin ;
Shan, Hong .
RADIOLOGY, 2020, 295 (01) :202-207
[6]   Time to surgery in thoracic cancers and prioritization during COVID-19: a systematic review [J].
Fligor, Scott C. ;
Tsikis, Savas T. ;
Wang, Sophie ;
Ore, Ana Sofia ;
Allar, Benjamin G. ;
Whitlock, Ashlyn E. ;
Calvillo-Ortiz, Rodrigo ;
Arndt, Kevin ;
Callery, Mark P. ;
Gangadharan, Sidhu P. .
JOURNAL OF THORACIC DISEASE, 2020, 12 (11) :6640-6654
[7]  
Fujimoto Hiroki, 2011, Osaka City Med J, V57, P21
[8]   Growth rate of small lung cancers detected on mass CT screening [J].
Hasegawa, M ;
Sone, S ;
Takashima, S ;
Li, F ;
Yang, ZG ;
Maruyama, Y ;
Watanabe, T .
BRITISH JOURNAL OF RADIOLOGY, 2000, 73 (876) :1252-1259
[9]   CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds [J].
Henschke, Claudia I. ;
Yip, Rowena ;
Smith, James P. ;
Wolf, Andrea S. ;
Flores, Raja M. ;
Liang, Mingzhu ;
Salvatore, Mary M. ;
Liu, Ying ;
Xu, Dong Ming ;
Yankelevitz, David F. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (06) :1176-1184
[10]   Pulmonary Ground-Glass Opacity (GGO) Lesions-Large Size and a History of Lung Cancer are Risk Factors for Growth [J].
Hiramatsu, Miyako ;
Inagaki, Takuya ;
Inagaki, Tomoya ;
Matsui, Yoshio ;
Satoh, Yukitoshi ;
Okumura, Sakae ;
Ishikawa, Yuichi ;
Miyaoka, Etsuo ;
Nakagawa, Ken .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (11) :1245-1250